Open AccessUse of immunobiological drugs in the treatment of rheumatoid arthritis
Author(s) -
М. В. Волкова,
A. V. Kunder
Publication year - 2019
Publication title -
vescì nacyânalʹnaj akadèmìì navuk belarusì. seryâ medycynskìh navuk
Language(s) - English
Resource type - Journals
eISSN - 2524-2350
pISSN - 1814-6023
DOI - 10.29235/1814-6023-2018-15-4-493-502
Subject(s) - rheumatoid arthritis , medicine , biological drugs , concomitant , disease , immunology
In this article, we discuss the modern approaches to optimize rheumatoid arthritis therapy with biological antiinflammatory drugs using specific predictors. We describe the most important predictors such as body mass index, smoking, disease activity, concomitant therapy, and the presence of antibodies in predicting the effectiveness of biologicals. Also, we provide data on the ability to predict the response to a certain type of biological therapy on the basis of clinical variants of rheumatoid arthritis.